Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Clinical trial NCT00224055 · COMPLETED

Trial details

NCT number: NCT00224055
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Anemia, Iron-Deficiency Kidney Failure, Chronic

Start date: 2003-04-01
Primary completion: 2004-09-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.